CLEVELAND, July 12, 2011 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the addition of Triangle Biostatistics, LLC. to its Connect Partner Program. The partnership will extend the reach of DATATRAK Clinical and Consulting Services™ (DCCS) to enable customers to receive strong statistical consulting and programming support from experienced industry professionals.

"We are excited about working with DATATRAK's Clinical and Consulting Services to expand the offerings to their clients," said Dr. Charles Wakeford, Managing Member of Triangle Biostatistics. "By combining efforts, the partnership will provide statistical consulting and programming services to the DATATRAK customers."

"This partnership will allow DCCS to expand its services offering," said Dr. Bill Gluck, DATATRAK's Vice President of Clinical and Consulting Services. "Having Triangle Biostatistics as part of the Connect Partner Program is an invaluable resource to the DATATRAK customer community; we are thrilled about this partnership."

About Triangle Biostatistics, LLC.

Triangle Biostatistics was founded to provide statistical consulting and statistical programming services to the pharmaceutical industry. With over 50 years of combined years of experience in all phases of drug development, Triangle Biostatistics is positioned to provide strong statistical consulting and programming support utilizing sound scientific reasoning and the latest computing technology. Please see http://www.trianglebiostatistics.com for more information.

About DATATRAK International, Inc.

DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ unified software suite, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the OTCQX Market announcing its results for the three-month period ending March 31, 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.

Back to top

RELATED LINKS
http://www.datatrak.net